U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07680478) titled 'Nutrition Intervention Combined With Resmetirom for MASH' on June 18.
Brief Summary: This randomized control trial aims to evaluate the effectiveness of combining resmetirom therapy (first approved pharmacological therapy for treating metabolic dysfunction-associated steatohepatitis (MASH)) with a nutritional intervention compared to resmetirom therapy alone over one year in improving liver health among 120 patients living with non-cirrhotic MASH. We hypothesize that patients receiving resmetirom and nutritional intervention will experience more significant improvements in liver function than those receiving only resmetirom therapy....